A therapeutic alternative for haemophiliacs with inhibitors

This publication has 8 references indexed in Scilit:

• PROLONGED RECOMBINANT ACTIVATED FACTOR VII (rFVIIa) TREATMENT FOR SEVERE BLEEDING IN A FACTOR‐IX‐DEFICIENT PATIENT WITH AN INHIBITOR
  British Journal of Haematology, 1991
• Mechanism by which recombinant factor VIIa shortens the aPTT: Activation of factor X in the absence of tissue factor
  Thrombosis Research, 1989
• Use of recombinant activated factor VII for treatment of a retropharyngeal hemorrhage in a hemophilic patient with a high titer inhibitor
  American Journal of Hematology, 1989
• Clinical Experience with Human Plasma-Derived Factor VIla in Patients with Hemophilia A and High Titer Inhibitors
  Pathophysiology of Haemostasis and Thrombosis, 1989
• SUCCESSFUL USE OF RECOMBINANT FACTOR VIIa IN PATIENT WITH SEVERE HAEMOPHILIA A DURING SYNOVECTOMY
  The Lancet, 1988
• Use of human factor VIIa in the treatment of two hemophilia A patients with high-titer inhibitors.
  Journal of Clinical Investigation, 1983
• A Survey of 215 Non-Hemophilic Patients with Inhibitors to Factor VIII
  Thrombosis and Haemostasis, 1981